Document Detail


Effect of low-dose cisapride on gastric emptying and QTc interval in preterm infants.
MedLine Citation:
PMID:  11195234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSIONS: Cisapride significantly shortened both gastric emptying time and QTc interval (p < 0.05) compared to placebo. All infants completed the study without any apparent adverse effects. In conclusion, low-dose cisapride administration significantly improves gastric emptying without increasing the QTc interval.
Authors:
C Costalos; A Gounaris; E Varhalama; F Kokori; N Alexiou; I Katsarakis
Related Documents :
7710574 - Neonatal neutropenia in low birthweight premature infants.
6683214 - Sibling birthweights and maternal age in sids cases.
1483814 - Reinterpreting the effects of maternal smoking on infant birthweight and perinatal mort...
2265974 - Birth weight and pathogenesis in phenylketonuria.
2388784 - Semipermeable dressing and transepidermal water loss in premature infants.
9277014 - Hypoglycaemia of the newborn: a review.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta paediatrica (Oslo, Norway : 1992)     Volume:  89     ISSN:  0803-5253     ISO Abbreviation:  Acta Paediatr.     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-01-18     Completed Date:  2001-03-15     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  9205968     Medline TA:  Acta Paediatr     Country:  Norway    
Other Details:
Languages:  eng     Pagination:  1446-8     Citation Subset:  IM    
Affiliation:
Department of Neonatal Medicine, Regional General Hospital of Piraeus, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Cisapride / pharmacology*
Female
Gastric Emptying / drug effects*
Gastrointestinal Agents / pharmacology*
Humans
Infant, Newborn
Infant, Very Low Birth Weight
Male
Prospective Studies
Stomach / ultrasonography
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents; 81098-60-4/Cisapride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dextran reduces surfactant inhibition by meconium.
Next Document:  Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high ...